Holen Sie sich die Stockscreener-App
25.25
7.04%
1.66
Handel nachbörslich:
25.25
Schlusskurs vom Vortag:
$23.59
Offen:
$25.42
24-Stunden-Volumen:
5.36M
Relative Volume:
5.06
Marktkapitalisierung:
$1.98B
Einnahmen:
$399.58M
Nettoeinkommen (Verlust:
$-54.04M
KGV:
-33.67
EPS:
-0.75
Netto-Cashflow:
$40.13M
1W Leistung:
+7.40%
1M Leistung:
-4.54%
6M Leistung:
-42.36%
1J Leistung:
+6.27%
1-Tages-Spanne:
$24.80
$26.11
1-Wochen-Bereich:
$22.96
$26.11
52-Wochen-Spanne:
$19.73
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Firmenname
Veracyte Inc
Sektor
Branche
Telefon
(650) 243-6300
Adresse
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Vergleichen Sie VCYT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
25.25 | 1.85B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
478.32 | 179.32B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.48 | 145.22B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
565.19 | 44.23B | 3.93B | 894.97M | 837.70M | 10.82 |
|
IQV
Iqvia Holdings Inc
|
199.17 | 34.14B | 15.50B | 1.33B | 2.16B | 7.34 |
|
A
Agilent Technologies Inc
|
120.18 | 34.19B | 6.63B | 1.17B | 1.19B | 4.05 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | Craig Hallum | Buy |
| 2024-12-05 | Herabstufung | Goldman | Buy → Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-10-16 | Eingeleitet | UBS | Buy |
| 2024-10-10 | Eingeleitet | Guggenheim | Buy |
| 2024-02-23 | Bestätigt | Needham | Buy |
| 2023-01-18 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-01-07 | Eingeleitet | Stephens | Overweight |
| 2021-11-18 | Fortgesetzt | Goldman | Buy |
| 2021-06-15 | Eingeleitet | Raymond James | Outperform |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2019-07-31 | Eingeleitet | Lake Street | Buy |
| 2019-07-02 | Eingeleitet | Needham | Buy |
| 2018-11-29 | Herabstufung | Janney | Buy → Neutral |
| 2018-10-31 | Hochstufung | Janney | Neutral → Buy |
| 2017-11-07 | Herabstufung | Janney | Buy → Neutral |
| 2017-11-07 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | Fortgesetzt | BTIG Research | Buy |
| 2016-11-14 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-18 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-11 | Bestätigt | Leerink Partners | Outperform |
| 2013-11-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
What are analysts’ price targets for Veracyte Inc. in the next 12 monthsExceptional profit margins - jammulinksnews.com
How strong is Veracyte Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion - MSN
How does Veracyte Inc. generate profit in a changing economyRobust investment performance - jammulinksnews.com
What is the risk reward ratio of investing in Veracyte Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
What institutional investors are buying Veracyte Inc. stockInvest confidently with proven investment plans - jammulinksnews.com
Why Veracyte Inc. stock attracts strong analyst attentionFree Exclusive Group - Metal.it
What analysts say about Veracyte Inc. stockUnprecedented growth rates - PrintWeekIndia
Veracyte stock soars after S&P SmallCap 600 addition announcement By Investing.com - Investing.com India
Veracyte stock soars after S&P SmallCap 600 addition announcement - Investing.com
Veracyte Inc. Stock Analysis and ForecastDynamic profit opportunities - PrintWeekIndia
Veracyte jumps after diagnostics company to join S&P 600 Small Cap Index - TradingView
Veracyte Set to Join S&P SmallCap 600 | VCYT Stock News - GuruFocus
Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Small-Cap Healthcare Innovation - AInvest
Veracyte Set to Join S&P SmallCap 600 - 富途牛牛
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel - 富途牛牛
What drives Veracyte Inc. stock pricePhenomenal investment performance - Autocar Professional
Is Veracyte Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
Published on: 2025-07-22 20:34:08 - jammulinksnews.com
CSBR names Veracyte exec Robert Brainin CEO; 700K option package | DNN SEC FilingForm 6-K - Stock Titan
Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st
Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Should You Continue to Hold Veracyte Stock in Your Portfolio Now? - MSN
Oversold Conditions For Veracyte (VCYT) - Nasdaq
When is the best time to buy Veracyte Inc. stockMinimized Risk Maximum Return - Newser
Will Veracyte Inc. stock split in the near futureBreakout Momentum Stocks - Newser
Veracyte, Inc. (NASDAQ:VCYT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Finanzdaten der Veracyte Inc-Aktie (VCYT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.50%
1.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):